Company Profile

Analiza Inc
Profile last edited on: 2/14/19      CAGE: 3V1F6      UEI:

Business Identifier: NO Business Identifier is currently available for this company.
Year Founded
1996
First Award
1997
Latest Award
2004
Program Status
Inactive
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

3615 Superior Avenue Suite 4407b
Cleveland, OH 44114
   (216) 432-9050
   info@analiza.com
   www.analiza.com
Location: Single
Congr. District: 11
County: 

Public Profile

ANALIZA, Inc. is a privately held corporation dedicated to discovering, developing, and commercializing new technologies for the life sciences. ANALIZA provides integrated solutions to key applications in the pharmaceutical, biotechnology and diagnostics industries. ANALIZA has pioneered unique technologies and solutions in four key areas: * Automated analysis of physicochemical and pharmacokinetic (ADME) properties of small-molecule drug candidates * Rapid characterization of structural aspects of biomolecules such as proteins * Purification, formulation, and analysis of protein therapeutics * Discovery and screening of protein biomarkers for cancer and other diseases. Cancer diagnostics is the focus of the firm'ssubsidiary AnalizaDx, LLC

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
5-9
Revenue Range
.5M-1M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
10-14

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2004 1 NIH $120,567
Project Title: Structural Signatures for Quality Control of Proteins
2002 2 NIH $1,071,883
Project Title: New Method for Qsar for Biopharmaceutical Products
2002 1 NIH $99,242
Project Title: Rapid Quality Control Technology for Biodefense Vaccines
1999 2 NIH $849,933
Project Title: Microheterogeneity in Bioproducts
1997 1 NIH $94,588
Project Title: New Method for Measurement of CDT Level in Serum

Key People / Management

  Mark Stratton

  Boris Y Zaslavsky

Company News

There are no news available.